The US Food and Drug Administration (FDA) has conditionally approved TransMedics Group’s investigational device exemption (IDE) to commence the next-generation OCS ENHANCE Heart study. Part A of the ...

April 17, 2006 — Editor's Note: Cardiocerebral resuscitation (CCR) — employing chest compressions but no ventilations — improves survival of out-of-hospital cardiac arrest, according to the results of ...

Add Yahoo as a preferred source to see more of our stories on Google. Part B aims to expand clinical indications for OCS Heart to include standard criteria DBD hearts transplanted within four hours.

The much-anticipated Flyrcado™ (flurpiridaz F 18) injection, a first-of-its-kind unit dose positron emission tomography myocardial perfusion imaging agent for the detection of coronary artery disease, ...

A new medical technology expected to be on the market in 2027 is poised to help patients in middle America have greater access to heart transplants. Xvivo Perfusion, a leader in organ transplant ...